Cargando…

Levosimendan therapy does not improve survival of post-resuscitation cardiogenic shock patients

Detalles Bibliográficos
Autores principales:	Soos, P, Becker, D, Barczi, G, Szabo, G, Zima, E, Fulop, G, Geller, L, Apor, A, Merkely, B
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4084058/ http://dx.doi.org/10.1186/cc7336

Ejemplares similares

Retrospective study of proarrhythmic effects of levosimendan during the therapy of heart failure
por: Zima, E, et al.
Publicado: (2007)

Percutaneous coronary intervention in acute coronary syndrome complicated by states Killip 3 and 4 in 2005
por: Zima, E, et al.
Publicado: (2007)

Levosimendan in patients with acute cardiogenic shock, not responders to conventional therapy
por: Vetrugno, L, et al.
Publicado: (2007)

Effects of levosimendan in acute heart failure, cardiogenic and septic shock
por: Alhashemi, JA, et al.
Publicado: (2008)

Hemodynamic and echographic effects of levosimendan in patients with cardiogenic shock refractory to catecholamines
por: Labbene, I, et al.
Publicado: (2006)

Acute liver failure induced by intravenous amiodarone in the cardiac care unit: retrospective study of 3 years
por: Zima, E, et al.
Publicado: (2009)

Levosimendan does not improve resuscitation success after hypovolemic cardiac arrest
por: Semenas, E, et al.
Publicado: (2008)

Efficacy of levosimendan in shock
por: McLean, A, et al.
Publicado: (2004)

Magnitude of first medical contact in the long-term prognosis of patients treated with STEMI
por: Becker, D, et al.
Publicado: (2010)

Acute coronary syndrome associated cardiogenic shock in the catheterization laboratory: peripheral veno-arterial extracorporeal membrane oxygenator management and recommendations
por: Ehrenberger, Réka, et al.
Publicado: (2023)

Levosimendan versus dobutamine in septic shock
por: Alhashemi, JA, et al.
Publicado: (2009)

Levosimendan Improves Oxidative Balance in Cardiogenic Shock/Low Cardiac Output Patients
por: Grossini, Elena, et al.
Publicado: (2020)

Cardiogenic shock: an experimental animal model
por: Tanamati, C, et al.
Publicado: (2005)

Effects of levosimendan and inhaled nitric oxide on microcirculation in septic shock
por: Morelli, A, et al.
Publicado: (2009)

Levosimendan for resuscitating the microcirculation in patients with septic shock: a randomized controlled study
por: Morelli, Andrea, et al.
Publicado: (2010)

Vasopressors and inotropes in cardiogenic shock: is there room for “adrenaline resuscitation”?
por: Morici, Nuccia, et al.
Publicado: (2016)

Early Levosimendan Administration Improved Weaning Success Rate in Extracorporeal Membrane Oxygenation in Patients With Cardiogenic Shock
por: Chen, Yu-Wen, et al.
Publicado: (2022)

Levosimendan neither improves nor worsens mortality in patients with cardiogenic shock due to ST-elevation myocardial infarction
por: Omerovic, Elmir, et al.
Publicado: (2010)

Can levosimendan reduce ECMO weaning failure in cardiogenic shock?: a cohort study with propensity score analysis
por: Guilherme, Enrique, et al.
Publicado: (2020)

Infections after myocardial infarction and cardiogenic shock and their reflection by inflammation parameters
por: Mitterhammer, H, et al.
Publicado: (2005)

Effects of levosimendan on renal function in septic shock: a case–control study
por: Morelli, A, et al.
Publicado: (2009)

Copeptin is a strong and independent predictor of outcome in cardiogenic shock
por: Meyer, B, et al.
Publicado: (2009)

Correction to: Can levosimendan reduce ECMO weaning failure in cardiogenic shock?: a cohort study with propensity score analysis
por: Guilherme, Enrique, et al.
Publicado: (2020)

Addition of levosimendan to overcome acute cardiogenic shock—Paving the way for later heart transplantation—A first case report
por: Flottmann, Christian, et al.
Publicado: (2020)

Synergistic effects of levosimendan and convalescence plasma as bailout strategy in acute cardiogenic shock in COVID-19: A case report
por: Fox, Henrik, et al.
Publicado: (2022)

Levosimendan in cardiac surgery
por: Harjola, V, et al.
Publicado: (2004)

Treatment of calcium channel blocker overdose with levosimendan
por: Sencan, A, et al.
Publicado: (2011)

Long-term outcome after angioplasty in cardiogenic shock
por: Bulpa, P, et al.
Publicado: (2004)

Cardiogenic shock in the Aachen Digital Myocardial Infarction Registry
por: Kersten, A, et al.
Publicado: (2007)

Effects of levosimendan on cellular metabolic alterations in patients with septic shock: a randomised controlled study
por: Meddeb, B, et al.
Publicado: (2015)

Perioperative risk factors for serious gastrointestinal complications treated by laparotomy after cardiac surgery using cardiopulmonary bypass
por: Soos, P, et al.
Publicado: (2011)

Comparison of balanced and unbalanced crystalloids as resuscitation fluid in patients treated for cardiogenic shock
por: Gmeiner, Jonas, et al.
Publicado: (2023)

Levosimendan: experience of an adult ICU
por: Lippett, S, et al.
Publicado: (2006)

Heart rate variability in the early resuscitation of septic shock
por: Arnold, RC, et al.
Publicado: (2009)

Effectiveness of levosimendan and role of cardiac magnetic resonance in cardiogenic shock due to COVID-19 related lymphocytic myocarditis in the course of viral sepsis
por: Mangini, Francesco, et al.
Publicado: (2023)

Initiation of ivabradine in cardiogenic shock
por: Chiu, Michael H., et al.
Publicado: (2019)

Cardiogenic shock /
Publicado: (2002)

Cardiogenic Shock
por: Vahdatpour, Cyrus, et al.
Publicado: (2019)

Levosimendan versus dobutamine in cardiac surgery
por: Delgado-Amaya, MD, et al.
Publicado: (2015)

Intra-aortic balloon counterpulsation: impact on patient hemodynamics in acute myocardial infarction complicated by cardiogenic shock
por: Brazdzionyte, J, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_t1jdd37sqthjucn4mtuble5ns7